NASDAQ:SLRN - Nasdaq - US00445A1007 - Common Stock
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 324.85M | 422.06M | 69.18M | 41.79M | |||
Research and Development | 249.40M | 355.89M | 55.63M | 38.23M | |||
Selling, General, and Administrative Expenses | 75.45M | 66.18M | 13.55M | 3.56M | |||
Operating Income | -324.85M | -422.06M | -69.18M | -41.79M | |||
Interest Income/Expense | 35.20M | 40.85M | 4.54M | 0.00 | |||
Other Income/Expense | 36.05M | -423.00K | -132.00K | -45.00K | |||
Income Before Taxes | -264.40M | -381.64M | -64.77M | -41.84M | |||
Net Income | -264.40M | -381.64M | -64.77M | -41.84M | |||
EBITDA | -324.52M | -421.95M | N/A | N/A | |||
Per Share Data | |||||||
EPS Diluted Total Ops | -2.68 | -3.88 | -0.70 | -0.45 | |||
Non GAAP EPS | -2.68 | -4.35 | N/A | N/A | |||
Statistics |
All data in USD